Diamond Biofund Inc. (6901.TW)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in TWDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | TWD m | 0 | 0 | 0 | 0 | 0 | -1 | - | - |
| Operating profit | TWD m | -1,279 | - | ||||||
| Net profit | TWD m | 6,090 | 2,852 | 798 | -2,583 | -2,518 | -1,175 | - | - |
| EPS reported | TWD | -1.38 | - | ||||||
| Operating cashflow per share | TWD | -0.19 | - | ||||||
| Capex per share | TWD | 0.00 | - | ||||||
| FCF per share | TWD | -0.19 | - | ||||||
| Free cash flow | TWD m | -166 | - | ||||||
| Net debt | TWD m | -3,891 | - | ||||||
| Book value equity | TWD m | 9,221 | - | ||||||
| Book value per share | TWD | 10.82 | - | ||||||
| Number of shares | m | 851.97 | - | ||||||
| DPS (TTM paid) | TWD | 0.00 | - |
Financial summary
Financials in TWDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 1.52 | - | ||||||
| P/S LTM | x | -23,586.39 | - | ||||||
| P/FCF LTM | x | -84.63 | - | ||||||
| EV/EBITDA LTM | x | -9.97 | - | ||||||
| EV/Sales LTM | x | -19,119.00 | - | ||||||
| Earnings Yield LTM | % | -8.36% | - | ||||||
| FCF Yield | % | -1.18% | - | ||||||
| Quality | |||||||||
| ROE | % | -12.74% | - | ||||||
| ROIC | % | -13.66% | - | ||||||
| Operating margin | % | +2145.25% | - | ||||||
| Gross margin | % | +47.95% | - | ||||||
| FCF/Sales | % | +27871.14% | - | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | - | - | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | - | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | - | ||||||
| FCF/Debt | x | -1.77 | - | ||||||
| Net Debt/EBITDA | x | 2.33 | - | ||||||
| EBIT/Net interest | x | -414.04 | - | ||||||
| Net debt/market cap | % | 0.00% | - | ||||||
| Net debt/Equity | x | -0.42 | - | ||||||
| Gross debt/equity | x | 0.01 | - | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Diamond Biofund Inc. (6901.TW)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free